Anti-Human EGFR Therapeutic Antibody (Futuximab)
Recombinant Chimeric (human/mouse) antibody to Human EGFR. Futuximab (INN) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and also binds to HER1.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-H35 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | EGFR |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | IF, WB, Inhib |